Holen Sie sich die Stockscreener-App
0.1284
0.16%
0.0002
Schlusskurs vom Vortag:
$0.1282
Offen:
$0.1275
24-Stunden-Volumen:
4.65M
Relative Volume:
1.04
Marktkapitalisierung:
$125.63M
Einnahmen:
$25.19M
Nettoeinkommen (Verlust:
$-34.53M
KGV:
-5.5826
EPS:
-0.023
Netto-Cashflow:
$-20.62M
1W Leistung:
-2.13%
1M Leistung:
+6.20%
6M Leistung:
-27.05%
1J Leistung:
-24.69%
1-Tages-Spanne:
$0.1274
$0.131
1-Wochen-Bereich:
$0.127
$0.1354
52-Wochen-Spanne:
$0.117
$0.2285
Zomedica Corp Stock (ZOM) Company Profile
Firmenname
Zomedica Corp
Sektor
Telefon
734-369-2555
Adresse
100 Phoenix Drive, Suite 190, Ann Arbor, MI
Vergleichen Sie ZOM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ZOM
Zomedica Corp
|
0.1284 | 125.63M | 25.19M | -34.53M | -20.62M | -0.023 |
|
ZTS
Zoetis Inc
|
176.74 | 80.59B | 9.15B | 2.43B | 2.31B | 4.92 |
|
HLN
Haleon Plc Adr
|
9.72 | 44.17B | 14.26B | 1.55B | 0 | 0.3327 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.57 | 42.61B | 30.27B | 1.93B | 3.45B | 0.444 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.57 | 18.77B | 16.77B | -959.00M | 1.37B | -2.00 |
|
VTRS
Viatris Inc
|
13.22 | 15.73B | 15.05B | -883.30M | 1.89B | 1.53 |
Zomedica Corp Stock (ZOM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-06 | Eingeleitet | Dawson James | Buy |
Zomedica Corp Aktie (ZOM) Neueste Nachrichten
Zomedica to Present at the NobleCon20 Twentieth Annual Emerging Growth Equity Conference December 4, 2024 - AccessWire
Zomedica CEO to Present at NobleCon20 Conference, Investor Meetings Scheduled | ZOM Stock News - StockTitan
Zomedica secures new lease for headquarters expansion By Investing.com - Investing.com South Africa
Zomedica secures new lease for headquarters expansion - Investing.com
Noble Financial Predicts Zomedica FY2024 Earnings - MarketBeat
Zomedica Launches Quantitative Insulin Assay for Equine Plasma on the TRUFORMA(R) Platform - AccessWire
Zomedica Launches 18-Minute Equine Insulin Test, Expands TRUFORMA Platform Capabilities | ZOM Stock News - StockTitan
Johnny D. Powers Purchases 100,000 Shares of Zomedica Corp. (NYSEAMERICAN:ZOM) Stock - MarketBeat
Zomedica (NYSEAMERICAN:ZOM) Stock Rating Upgraded by Noble Financial - MarketBeat
Noble Capital Markets Initiates Equity Research Coverage on Zomedica - WICZ
Zomedica (ZOM) Launches Noble Capital Markets Coverage to Boost Market Visibility | ZOM Stock News - StockTitan
Zomedica initiated with an Outperform at Noble Capital - TipRanks
Zomedica Corp. (AMEX:ZOM) Q3 2024 Earnings Call Transcript - Insider Monkey
Zomedica Corp (ZOM) Q3 2024 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... By GuruFocus - Investing.com Canada
Earnings call: Zomedica reports record Q3 revenue, eyes future growth By Investing.com - Investing.com Australia
Zomedica stock plunges to 52-week low of $0.12 amid market challenges By Investing.com - Investing.com South Africa
Earnings call: Zomedica reports record Q3 revenue, eyes future growth - Investing.com
Zomedica’s Revenue Up 10% Amid Global Expansion - TipRanks
Zomedica stock plunges to 52-week low of $0.12 amid market challenges - Investing.com India
Zomedica to Present at the Sidoti Micro Cap Conference November 14, 2024 - Herald Palladium
Zomedica CEO to Present at Sidoti Micro Cap Conference, Showcases Pet Health Innovation | ZOM Stock News - StockTitan
Zomedica Corp Posts Increased Revenue Amid Loss - TipRanks
Zomedica Announces Third Quarter 2024 Financial Results: Revenue - WICZ
Zomedica Announces Third Quarter 2024 Financial Results: Revenue Up 10% to $7 Million; 72% Gross Margin, and $78 Million in Liquidity to Support Growth - AccessWire
Zomedica Q3 Revenue Jumps 10%, Diagnostics Surges 38% Despite Wider Losses | ZOM Stock News - StockTitan
Zomedica stock plunges to 52-week low at $0.12 amid market challenges - Investing.com India
ZOMZomedica Corp. Latest Stock News & Market Updates - StockTitan
Zomedica Launches Ear Cytology Quick Scan Protocol for TRUVIEW(TM) Digital Microscope & Telepathology Platform - AccessWire
Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET - AccessWire
Zomedica stock plunges to 52-week low at $0.12 amid market challenges By Investing.com - Investing.com South Africa
Adversity is less terrifying than hope: Zomedica Corp (ZOM) - SETE News
Stock Market Recap: Zomedica Corp (ZOM) Concludes at 0.13, a -2.01 Surge/Decline - The Dwinnex
Zomedica Announces Sponsorship of Educational Presentations at the Fetch Coastal Conference - Lelezard
Zomedica Corp’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - The InvestChronicle
Zomedica Corp [ZOM] stock Initiated by Dawson James analyst, price target now $6 - The DBT News
Daily Market Movement: Zomedica Corp (ZOM) Sees a -0.46 Decrease, Closing at 0.13 - The Dwinnex
CEO HEATON LARRY C II acquired 100,000 shares of Zomedica Corp [ZOM] - Knox Daily
What technical indicators reveal about ZOM stock - US Post News
Zomedica Corp Inc. (ZOM) Price Performance: A Fundamental Analysis Perspective - The InvestChronicle
There is no way Zomedica Corp (ZOM) can keep these numbers up - SETE News
Understanding the Risks of Investing in Zomedica Corp (ZOM) - Knox Daily
Zomedica expands distribution agreement in Europe with Grovet - MSN
ZOM’s valuation metrics: A comprehensive analysis - US Post News
Zomedica Strengthens European Foothold With Grovet Partnership, Expanding PulseVet And TRUFORMA Reach - Benzinga
Zomedica Corp (ZOM) Stock: A Year of Decreases and Increases - The InvestChronicle
Zomedica Announces Expansion of Exclusive Equine Distribution Agreement with Grovet in Europe - Herald Palladium
Finanzdaten der Zomedica Corp-Aktie (ZOM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.83%
1.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):